[go: up one dir, main page]

AU2002357701A1 - Polymorphs of fexofenadine base - Google Patents

Polymorphs of fexofenadine base

Info

Publication number
AU2002357701A1
AU2002357701A1 AU2002357701A AU2002357701A AU2002357701A1 AU 2002357701 A1 AU2002357701 A1 AU 2002357701A1 AU 2002357701 A AU2002357701 A AU 2002357701A AU 2002357701 A AU2002357701 A AU 2002357701A AU 2002357701 A1 AU2002357701 A1 AU 2002357701A1
Authority
AU
Australia
Prior art keywords
polymorphs
fexofenadine base
fexofenadine
base
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002357701A
Inventor
Judith Aronhime
Dov Diller
Ben-Zion Dolitzky
Barnaba Krochmal
Shlomit Wizel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/118,807 external-priority patent/US20020177608A1/en
Priority claimed from US10/133,460 external-priority patent/US20030021849A1/en
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2002357701A1 publication Critical patent/AU2002357701A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002357701A 2001-11-08 2002-11-08 Polymorphs of fexofenadine base Abandoned AU2002357701A1 (en)

Applications Claiming Priority (23)

Application Number Priority Date Filing Date Title
US33693001P 2001-11-08 2001-11-08
US60/336,930 2001-11-08
US33904101P 2001-12-07 2001-12-07
US60/339,041 2001-12-07
US34411401P 2001-12-28 2001-12-28
US60/344,114 2001-12-28
US36178002P 2002-03-04 2002-03-04
US60/361,780 2002-03-04
US36348202P 2002-03-11 2002-03-11
US60/363,482 2002-03-11
US10/118,807 US20020177608A1 (en) 2001-04-09 2002-04-08 Polymorphs of fexofenadine hydrochloride
US10/118,807 2002-04-08
US10/133,460 2002-04-26
US10/133,460 US20030021849A1 (en) 2001-04-09 2002-04-26 Polymorphs of fexofenadine hydrochloride
US38767002P 2002-06-10 2002-06-10
US60/387,670 2002-06-10
US39019802P 2002-06-19 2002-06-19
US60/390,198 2002-06-19
US40376502P 2002-08-15 2002-08-15
US60/403,765 2002-08-15
US40621402P 2002-08-27 2002-08-27
US60/406,214 2002-08-27
PCT/US2002/035996 WO2003039482A2 (en) 2001-11-08 2002-11-08 Polymorphs of fexofenadine base

Publications (1)

Publication Number Publication Date
AU2002357701A1 true AU2002357701A1 (en) 2003-05-19

Family

ID=29424979

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002357701A Abandoned AU2002357701A1 (en) 2001-11-08 2002-11-08 Polymorphs of fexofenadine base

Country Status (4)

Country Link
EP (1) EP1453509A2 (en)
AU (1) AU2002357701A1 (en)
CA (1) CA2465913A1 (en)
WO (1) WO2003039482A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
ITMI20041143A1 (en) * 2004-06-08 2004-09-08 Dipharma Spa FEXOFENADINA POLYMORPHS AND PROCEDURE FOR THEIR PREPARATION
ITMI20041568A1 (en) * 2004-07-30 2004-10-30 Dipharma Spa "BASE FEXOFENADINA POLYMORPHS"
EP1685106A2 (en) * 2004-09-28 2006-08-02 Teva Pharmaceutical Industries, Inc. Fexofendadine crystal form and processes for its preparation thereof
AU2014348523B2 (en) 2013-11-15 2019-01-03 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
ATE254594T1 (en) * 1993-06-24 2003-12-15 Albany Molecular Res Inc COMPOUNDS USABLE AS INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF PIPERIDINE DERIVATIVES
US6147216A (en) * 1993-06-25 2000-11-14 Merrell Pharmaceuticals Inc. Intermediates useful for the preparation of antihistaminic piperidine derivatives
US6201124B1 (en) * 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives

Also Published As

Publication number Publication date
WO2003039482A3 (en) 2003-11-20
WO2003039482A8 (en) 2005-01-06
EP1453509A2 (en) 2004-09-08
CA2465913A1 (en) 2003-05-15
WO2003039482A2 (en) 2003-05-15

Similar Documents

Publication Publication Date Title
AU2002305162A1 (en) Polymorphs of fexofenadine hydrochloride
AU2003226748A1 (en) Compositions of venlafaxine base
IL159036A0 (en) Increasing bioavailability of carotenoids
AU2002357701A1 (en) Polymorphs of fexofenadine base
IL161178A0 (en) MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
TW493722U (en) Improved structure of lampwick
IL161816A0 (en) Polymorphs of fexofenadine base
AU2002353803A1 (en) Direct resolution of racemic threo-methylphenidate hydrochloride
AU2002355679A1 (en) Fexofenadine polymorph
PL346451A1 (en) Novel derivative of l-homophenylamine
HU0104370D0 (en) Honeyed schnaps of oerseg
AU2003286352A1 (en) Process for the preparation of fexofenadine
AU2002347399A1 (en) Venlafaxine hydrochloride polymorphs
AU2002259114A1 (en) Preparation of paroxetine involving novel intermediates
AU2002317699A1 (en) Improved synthesis of allofuranose
AUPR908701A0 (en) Flexie base
TW493720U (en) Improved structure of candlestick
AU2001230627A1 (en) Anti-condensation base
AU2002313240A1 (en) Wall structure of base isolation structure
TW529397U (en) Assembly structure of San-Jieh stand
TW494780U (en) Structure of swimmeret
TW511737U (en) New structure of micro-radiator
TW510531U (en) New structure of micro-radiator
TW510530U (en) New structure of micro-radiator
TW499920U (en) Improved structure of hoverbed

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase